Search research articles
Contact Us
Filters
Showing results (61-70 of 86) with videos related to
Page
of 9
Sort By:
The Journal of Biological Chemistry
|
March 30, 2002
A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists
Wen-Bo Zhang, Jean-Marc Navenot, Bodduluri Haribabu, et al.
Plos One
|
October 3, 2012
Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model
Simone Buraschi, Thomas Neill, Rick T Owens, et al.
Biochemical and Biophysical Research Communications
|
March 12, 2004
Metastin and its variant forms suppress migration of pancreatic cancer cells
Toshihiko Masui, Ryuichiro Doi, Tomohiko Mori, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 10, 2008
Identification of novel non-peptide CXCR4 antagonists by ligand-based design approach
Satoshi Ueda, Manabu Kato, Shinsuke Inuki, et al.
International Journal of Cancer
|
December 30, 2009
Fluorescent imaging of high-grade bladder cancer using a specific antagonist for chemokine receptor CXCR4
Koji Nishizawa, Hiroyuki Nishiyama, Shinya Oishi, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 28, 2022
Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway
Xiang Li, Shaomin Wang, Wei Mu, et al.
Chembiochem : a European Journal of Chemical Biology
|
April 17, 2008
Synthesis and application of fluorescein- and biotin-labeled molecular probes for the chemokine receptor CXCR4
Shinya Oishi, Ryo Masuda, Barry Evans, et al.
Plos One
|
October 21, 2016
Immunohistochemistry Successfully Uncovers Intratumoral Heterogeneity and Widespread Co-Losses of Chromatin Regulators in Clear Cell Renal Cell Carcinoma
Wei Jiang, Essel Dulaimi, Karthik Devarajan, et al.
Organic & Biomolecular Chemistry
|
December 6, 2005
Structure-activity relationship studies on CXCR4 antagonists having cyclic pentapeptide scaffolds
Hirokazu Tamamura, Ai Esaka, Teppei Ogawa, et al.
Advances in Experimental Medicine and Biology
|
April 30, 2009
Development of chemokine receptor CXCR4 antagonists using bio-mimetic strategy
Hirokazu Tamamura, Tomohiro Tanaka, Hiroshi Tsutsumi, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 86) with videos related to
Sort By:
Page
of 9
The Journal of Biological Chemistry
|
March 30, 2002
A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists
Wen-Bo Zhang, Jean-Marc Navenot, Bodduluri Haribabu, et al.
Plos One
|
October 3, 2012
Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model
Simone Buraschi, Thomas Neill, Rick T Owens, et al.
Biochemical and Biophysical Research Communications
|
March 12, 2004
Metastin and its variant forms suppress migration of pancreatic cancer cells
Toshihiko Masui, Ryuichiro Doi, Tomohiko Mori, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 10, 2008
Identification of novel non-peptide CXCR4 antagonists by ligand-based design approach
Satoshi Ueda, Manabu Kato, Shinsuke Inuki, et al.
International Journal of Cancer
|
December 30, 2009
Fluorescent imaging of high-grade bladder cancer using a specific antagonist for chemokine receptor CXCR4
Koji Nishizawa, Hiroyuki Nishiyama, Shinya Oishi, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 28, 2022
Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway
Xiang Li, Shaomin Wang, Wei Mu, et al.
Chembiochem : a European Journal of Chemical Biology
|
April 17, 2008
Synthesis and application of fluorescein- and biotin-labeled molecular probes for the chemokine receptor CXCR4
Shinya Oishi, Ryo Masuda, Barry Evans, et al.
Plos One
|
October 21, 2016
Immunohistochemistry Successfully Uncovers Intratumoral Heterogeneity and Widespread Co-Losses of Chromatin Regulators in Clear Cell Renal Cell Carcinoma
Wei Jiang, Essel Dulaimi, Karthik Devarajan, et al.
Organic & Biomolecular Chemistry
|
December 6, 2005
Structure-activity relationship studies on CXCR4 antagonists having cyclic pentapeptide scaffolds
Hirokazu Tamamura, Ai Esaka, Teppei Ogawa, et al.
Advances in Experimental Medicine and Biology
|
April 30, 2009
Development of chemokine receptor CXCR4 antagonists using bio-mimetic strategy
Hirokazu Tamamura, Tomohiro Tanaka, Hiroshi Tsutsumi, et al.
Page
of 9